EVOLUTION: RWE from Saudi Arabia
Evaluating the clinical effectiveness and safety of insulin glargine 300 U/ml in individuals with T2D uncontrolled on Basal insulin: A real-world evidence study form Saudi Arabia (EVOLUTION).
![](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-sa/science/thumbnail/EVOLUTION---RWE-from-Saudi-Arabia.jpg/jcr:content/EVOLUTION%20-%20RWE%20from%20Saudi%20Arabia.jpg)
Related articles
MAT-BH-2300744/V1/NOV2023